Biosyent Inc (RX.V)
Biosyent Market Cap: 106.47M for May 23, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 23, 2024 | 106.47M |
May 22, 2024 | 104.27M |
May 21, 2024 | 104.27M |
May 17, 2024 | 104.27M |
May 16, 2024 | 98.47M |
May 15, 2024 | 95.52M |
May 14, 2024 | 97.03M |
May 13, 2024 | 98.70M |
May 10, 2024 | 98.70M |
May 09, 2024 | 99.75M |
May 08, 2024 | 98.82M |
May 07, 2024 | 100.45M |
May 06, 2024 | 98.82M |
May 03, 2024 | 100.45M |
May 02, 2024 | 100.91M |
May 01, 2024 | 100.91M |
April 30, 2024 | 99.86M |
April 29, 2024 | 100.21M |
April 26, 2024 | 98.82M |
April 25, 2024 | 98.82M |
April 24, 2024 | 97.54M |
April 23, 2024 | 97.54M |
April 22, 2024 | 97.54M |
April 19, 2024 | 98.70M |
April 18, 2024 | 98.12M |
Date | Value |
---|---|
April 17, 2024 | 99.28M |
April 16, 2024 | 99.28M |
April 15, 2024 | 100.33M |
April 12, 2024 | 100.45M |
April 11, 2024 | 99.86M |
April 10, 2024 | 99.63M |
April 09, 2024 | 99.86M |
April 08, 2024 | 100.45M |
April 05, 2024 | 100.10M |
April 04, 2024 | 100.45M |
April 03, 2024 | 99.86M |
April 02, 2024 | 100.45M |
April 01, 2024 | 100.91M |
March 28, 2024 | 101.03M |
March 27, 2024 | 101.03M |
March 26, 2024 | 100.91M |
March 25, 2024 | 101.03M |
March 22, 2024 | 100.21M |
March 21, 2024 | 101.03M |
March 20, 2024 | 99.75M |
March 19, 2024 | 98.70M |
March 18, 2024 | 99.75M |
March 15, 2024 | 98.82M |
March 14, 2024 | 99.98M |
March 13, 2024 | 100.45M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
Biocure Technology Inc | 1.41M |
Core One Labs Inc | 8.713M |
Nova Mentis Life Science Corp | 2.208M |
Nanosphere Health Sciences Inc | 0.3083M |
Lobe Sciences Ltd | 3.294M |
Market Cap Related Metrics
PE Ratio | 15.68 |
PS Ratio | 3.373 |
PEG Ratio | 0.3481 |
Price to Book Value | 3.081 |
Price to Free Cash Flow | 15.78 |
Price | 9.19 |
Earnings Yield | 6.38% |
PEGY Ratio | 0.3348 |
Operating PE Ratio | 13.55 |
Normalized PE Ratio | 15.66 |